Published in AIDS Weekly, August 19th, 1996
The hallmark of HIV disease is a marked decrease in CD4+ T cells. Antiretroviral therapies have long been evaluated in terms of their ability to reverse this trend.
But the new data suggest that clinicians will have to measure more than mere numbers to determine whether a patient's immune system has improved.
"An increase in T-cell counts is not necessarily associated with an increase in T-cell functional capacity," said Nadine G. Pakker of the Netherlands Red Cross Blood Transfusion Service,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.